EconPapers    
Economics at your fingertips  
 

Modelling Myc inhibition as a cancer therapy

Laura Soucek, Jonathan Whitfield, Carla P. Martins, Andrew J. Finch, Daniel J. Murphy, Nicole M. Sodir, Anthony N. Karnezis, Lamorna Brown Swigart, Sergio Nasi and Gerard I. Evan ()
Additional contact information
Laura Soucek: University of California, San Francisco, California 94143-0875, USA
Jonathan Whitfield: University of California, San Francisco, California 94143-0875, USA
Carla P. Martins: University of California, San Francisco, California 94143-0875, USA
Andrew J. Finch: University of California, San Francisco, California 94143-0875, USA
Daniel J. Murphy: University of California, San Francisco, California 94143-0875, USA
Nicole M. Sodir: University of California, San Francisco, California 94143-0875, USA
Anthony N. Karnezis: University of California, San Francisco, California 94143-0875, USA
Lamorna Brown Swigart: University of California, San Francisco, California 94143-0875, USA
Sergio Nasi: Istituto di Biologia e Patologia Molecolari, C.N.R., University La Sapienza
Gerard I. Evan: University of California, San Francisco, California 94143-0875, USA

Nature, 2008, vol. 455, issue 7213, 679-683

Abstract: Myc back in the limelight The Myc gene encodes for a transcription factor that is central to gene regulation in normal cells. It is also an oncogene, overexpressed or amplified in many different types of tumour. Though this makes it a candidate target for antitumour drugs, its involvement in many normal cell functions, lack of evidence of therapeutic efficacy and the difficulty of targeting it mean that it is not top of many lists of potential targets. That could change. Using a mouse model of Ras-dependent lung cancer in which Myc function can in effect be turned on and off, Soucek et al. show that inhibition of endogenous Myc triggers tumour regression. Significantly, although systemic inhibition of Myc has effects in other tissues, these were readily reversible, suggesting that Myc might be a valid anticancer target.

Date: 2008
References: Add references at CitEc
Citations: View citations in EconPapers (7)

Downloads: (external link)
https://www.nature.com/articles/nature07260 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:455:y:2008:i:7213:d:10.1038_nature07260

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/nature07260

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-03-19
Handle: RePEc:nat:nature:v:455:y:2008:i:7213:d:10.1038_nature07260